IFNG and COVID-19: In the context of COVID-19, an in vitro study demonstrated that IFN-γ can inhibit the replication cycle of SARS-CoV-2 in human epithelial cells through the generation of nitric oxide, which is an essential biological mediator in the immune system with broad antimicrobial activity against intracellular pathogens [124].